Medtronic, Inc. (Jobs) and Bayer Diabetes Care Announce Alliance to Provide Blood Glucose Meter to Medtronic, Inc. Patients Outside the United States

MINNEAPOLIS & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) and Bayer Diabetes Care, a division of Bayer HealthCare LLC and a member of the Bayer Group (NYSE:BAY), today announced an alliance to distribute and co-market a new blood glucose meter for Medtronic patients outside the United States beginning in Canada and Europe. The new meter, based on Bayer’s Contour® meter platform, will wirelessly transmit blood glucose test results directly to MiniMed Paradigm® insulin pumps and Guardian® REAL-Time continuous glucose monitoring (CGM) systems. Wireless communications make data entry easier and more convenient for patients.